Our Cases

Compass Lexecon has been involved in many of the largest and most complex antitrust litigation and financial market cases over the past 30 years.

Find a Case

Sorry, your search didn't return any results.

Compass Lexecon Client Mylan Prevails on Summary Judgment in EpiPen Antitrust Litigation

03/02/21

On December 17, 2020, the U.S. District Court for the District of Kansas granted summary judgment in favor of Compass Lexecon’s client Mylan Inc. on antitrust claims brought by Sanofi-Aventis U.S. LLC ("Sanofi"). Sanofi alleged that Mylan entered rebate agreements...

Compass Lexecon Client Prevails in Historic Delaware MAE Trial

10/15/18

Court Relies on Testimony of Compass Lexecon Expert Professor Daniel R. Fischel On October 1, 2018, Vice Chancellor J. Travis Laster of the Delaware Court of Chancery, relying on Compass Lexecon President Daniel Fischel's expert testimony on behalf of Compass...

King Drug Company of Florence, Inc. v. Cephalon, Inc., et al.

08/28/17

On August 28, 2017, the District Court in this case denied Plaintiffs’ motion to certify a class of direct purchasers of Cephalon’s branded drug Provigil. Direct purchaser Plaintiffs alleged that Cephalon delayed market entry of generic versions of Provigil through...

U.S. Second Circuit Court of Appeals finds in favor of American Express in U.S. et al. v. American Express Co. et al.

09/26/16

On September 26, 2016, the U.S. Second Circuit Court of Appeals ruled in favor of American Express in U.S. et al. v. American Express Co. et al. The Second Circuit reversed and remanded, with instructions to enter judgment in favor...